Professional Overview
Education History
| MD Candidate: | Stanford University School of Medicine, Medicine (2013) |
| Bachelor of Science: | California Institute of Technology, Biology (2008) |
| Transfer: | Pasadena City College, Biology (2005) |
Clerkships
| Calendar Year | Quarter | List of Clerkships |
|---|---|---|
| 2013 | Winter |
|
| 2012 | Autumn |
|
| Spring |
|
|
| Summer |
|
|
| Winter |
|
|
| 2011 | Autumn |
|
| Summer |
|
Work Experience
- Anatomy Tutor at Stanford Medical School, Stanford University School of Medicine (9/1/2009 - 12/1/2009)
- Researcher at Cheng Lab, Stanford University (8/1/2010 - 1/1/2012)
Scientific Focus
Research Projects
- Design, Synthesis, Characterization of an Acid-sensitive Bioconjugate of Affibody ZEGFR and Doxorubicin and Study of Its Therapeutic Effect on Breast Cancer Both in vivo and in vitro (MedScholars project)
- Monitoring Cancer Drug Therapy with Cerenkov Luminescence Imaging
- Novel Macromolecular Platform for Peptide Delivery to Prostate Cancer
- Profiling EGFR in a Breast Tumor Subtype using PET Imaging
Presentations
Publications
- Tyrosinase as a multifunctional reporter gene for Photoacoustic/MRI/PET triple modality molecular imaging. Sci Rep. 2013: 1490
- A Four-Arm Star-Shaped Poly(ethylene glycol) (StarPEG) Platform for Bombesin Peptide Delivery to Gastrin-Releasing Peptide Receptors in Prostate Cancer ACS Macro Letters. 2012; (6): 753-757
- Cerenkov Luminescence Imaging (CLI) for cancer therapy monitoring. J Vis Exp. 2012; (69): e4341
- Evaluation of Four Affibody-Based Near-Infrared Fluorescent Probes for Optical Imaging of Epidermal Growth Factor Receptor Positive Tumors. Bioconjug Chem. 2012
- Proof-of-concept study of monitoring cancer drug therapy with cerenkov luminescence imaging. J Nucl Med. 2012; (2): 312-7
- Harnessing the power of radionuclides for optical imaging: Cerenkov luminescence imaging. J Nucl Med. 2011; (12): 2009-18
Help